(function(){var loadHandler=window['sl_{4D8E5DBA-A9FD-4AA9-B20B-4FE82EEC1058}'];loadHandler&&loadHandler(10, '<div id="spr0_320eb2"><div id="spr1_320eb2" class="kern slide"><img id="img0_320eb2" src="data/img1.png" width="960px" height="720px" alt="" style="left:0px;top:0px;"/></div><div id="spr2_320eb2" class="kern slide"><div id="spr3_320eb2" style="left:48px;top:28.833px;"><div style="width:0px;"><span id="txt0_320eb2" data-width="299.119812" style="left:282.5px;top:17.379px;">DISCUSSION</span></div></div><div id="spr4_320eb2" style="left:48px;top:127.648px;"><div style="width:0px;"><span id="txt1_320eb2" class="nokern relpos" dir="auto" style="left:9.6px;top:5.26px;">•</span> <span id="txt2_320eb2" class="relpos" data-width="658.750000" style="left:34.397px;top:0.752px;">Expected most important outcomes of the study: </span> <span id="txt3_320eb2" class="relpos" data-width="106.968750" style="left:34.39px;top:0.752px;">reduced</span></div><div style="width:0px;"><span id="txt4_320eb2" data-width="483.078125" style="left:45.6px;top:39.152px;">MACE-3 events rate, improved QALY.</span></div><div style="width:0px;"><span id="txt5_320eb2" class="nokern relpos" dir="auto" style="left:9.6px;top:89.317px;">•</span> <span id="txt6_320eb2" class="relpos" data-width="616.546875" style="left:34.397px;top:84.81px;">Relationship of results with existing evidence: </span> <span id="txt7_320eb2" class="relpos" data-width="202.000000" style="left:34.39px;top:84.81px;">confirmation of</span></div><div style="width:0px;"><span id="txt8_320eb2" data-width="190.859375" style="left:45.6px;top:123.632px;">results by RCT.</span></div><div style="width:0px;"><span id="txt9_320eb2" class="nokern relpos" dir="auto" style="left:9.6px;top:173.797px;">•</span> <span id="txt10_320eb2" class="relpos" data-width="576.406250" style="left:34.397px;top:169.29px;">Limitations of design economic evaluation: </span> <span id="txt11_320eb2" class="relpos" data-width="179.687500" style="left:34.39px;top:169.29px;">private sector</span></div><div style="width:0px;"><span id="txt12_320eb2" data-width="815.265625" style="left:45.6px;top:208.112px;">patients are not included in NHS, compliance with medications</span></div><div style="width:0px;"><span id="txt13_320eb2" data-width="755.703125" style="left:45.6px;top:246.512px;">will not be evaluated, feasibility of recruiting of such great</span></div><div style="width:0px;"><span id="txt14_320eb2" data-width="842.000000" style="left:45.6px;top:284.912px;">number of patient and follow-up of them (very expensive study).</span></div><div style="width:0px;"><span id="txt15_320eb2" class="nokern relpos" dir="auto" style="left:9.6px;top:335.077px;">•</span> <span id="txt16_320eb2" class="relpos" data-width="616.390625" style="left:34.397px;top:330.57px;">Generalizability/ transferability of the results: </span> <span id="txt17_320eb2" class="relpos" data-width="176.843750" style="left:34.39px;top:330.57px;">same culture,</span></div><div style="width:0px;"><span id="txt18_320eb2" data-width="587.046875" style="left:45.6px;top:369.392px;">same food, same medications, same genetics</span></div><div style="width:0px;"><span id="txt19_320eb2" class="nokern relpos" dir="auto" style="left:9.6px;top:419.557px;">•</span> <span id="txt20_320eb2" class="relpos" data-width="387.140625" style="left:34.397px;top:415.05px;">Expected recommendations: </span> <span id="txt21_320eb2" class="relpos" data-width="448.687500" style="left:34.39px;top:415.05px;">Changing of guidelines in changing</span></div><div style="width:0px;"><span id="txt22_320eb2" data-width="817.921875" style="left:45.6px;top:453.872px;">of clinical work / what will be first line in therapy of DM type 2.</span></div></div></div></div>', '{"s":[]}');})();